Nonsteroidal MRA as a therapeutic option in patients with T2D and CKD10' education - July 17, 2023 - Tessa Laubscher, MD (Saskatoon, Canada), George L. Bakris, MD (Chicago, IL, USA), and Mikhail Kosiborod, MD (Kansas City, MO, USA)
This video was distributed by our partner, ReachMD, a leading online learning platform for physicians and other healthcare professionals.
- Tessa Laubscher, MD - Diabetes Consultant, Saskatoon Adult Diabetes Clinic and Insulin Task Force, Associate Professor Family Medicine, University of Saskatchewan, Saskatoon, Canada
- George L. Bakris, MD - Professor of Medicine, Director, AHA Comprehensive Hypertension Center, University of Chicago Medicine, Chicago, IL, USA
- Mikhail Kosiborod, MD - Professor of Medicine, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of PACE-cme.
This activity is supported by an independent educational grant from Bayer.